Cramer's lightning round: Watch out—momentum stocks are out of favor right now

  • It's that time again! "Mad Money" host Jim Cramer rang the lightning round bell, which means he gave his take on callers' favorite stocks at rapid speed.

Crispr Therapeutics AG: "Here's the problem: that's a momentum stock, and right now, momentum is out of favor so I cannot necessarily recommend that Crispr is the place to be."

Camping World Holdings: "I think it trades with Thor, frankly, whether it should or not, and Thor hit another 52-week low today, so I am going to say not yet, not yet, not yet."

Spectrum Pharmaceuticals: "No, man. If you're going to do that, you want to go high end. I want you [in] Amgen, which my charitable trust owns. Amgen's got this drug, Aimovig, which is taking the world by storm. It's an anti-migraine drug. Amgen is the one you want."

Avangrid Inc.: "All the utility stocks are going down. The two I'm recommending are Dominion now that it's finishing up the South Carolina situation, but more importantly, AEP."

Watch the full lightning round here:

Disclosure: Cramer's charitable trust owns shares of Amgen.

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram - Vine

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com